BioMarin Pharmaceutical Inc - Company Profile
Powered by 
All the sales intelligence you need on BioMarin Pharmaceutical Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BioMarin Pharmaceutical Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BioMarin Pharmaceutical Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on BioMarin Pharmaceutical Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4284441A1 | Application | Aav-produktionssysteme für aav-viruspartikel mit verbesserter infektiosität | C12N15/86; C12N2750/14122; C12N2750/14151; C07K14/005 | December 06, 2023 |
| CN117126151A | Application | 用于疾病治疗的乙醇酸氧化酶抑制剂 | A61K31/427; A61P13/00; C07D249/04; C07D249/06; C07D401/04; C07D401/06; C07D401/12; C07D401/14; C07D403/06; C07D403/12; C07D405/12; C07D409/12; C07D417/04; C07D417/12 | November 28, 2023 |
| CN117126152A | Application | 用于疾病治疗的乙醇酸氧化酶抑制剂 | A61K31/427; A61P13/00; C07D249/04; C07D249/06; C07D401/04; C07D401/06; C07D401/12; C07D401/14; C07D403/06; C07D403/12; C07D405/12; C07D409/12; C07D417/04; C07D417/12 | November 28, 2023 |
| US11821008B2 | Grant | Liver targeting adeno-associated viral vectors | C12N15/86; C12N2750/14121; C12N2750/14132; C12N2750/14141; C12N2750/14152; C12N7/00; A61K35/761; A61P1/16; C07K14/005 | November 21, 2023 |
| CN117069713A | Application | 用于疾病治疗的乙醇酸氧化酶抑制剂 | C07D401/04; C07D403/06; A61P13/00; C07D401/06; C07D401/12; C07D403/12; C07D409/12; C07D417/12; C07D401/14; C07D405/12; A61K31/427; C07D417/04; C07D249/06; C07D249/04 | November 17, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer